Dr. Anand completed her residency at Brigham and Women's Hospital before coming to Stanford for her nephrology fellowship.  She has remained on faculty at Stanford.  Her research interests are focused on the management of CKD and ESRD in developing, resource-poor areas, including India, Pakistan and Bangladesh.

Dr. Chang completed her MD at the University of Michigan and her internal medicine residency at the University of California, San Francisco.  She completed her fellowship and clinical research training at Stanford University, where she remains on faculty as an Assistant Professor and Director of Clinical Resesarch in the Division of Nephrology.   More Dr. Chang's research focuses on finding ways to reduce some of the evidence gaps regarding cardiovascular care in patients with kidney disease to ultimately improve outcomes. Specifically, she is interested in comparing the effectiveness of therapies for hypertension, coronary artery disease and peripheral arterial disease in people with kidney disease.  She is also involved in clinical trials, most recently as a site-PI for the Systolic Blood Pressure Intervension Trial (SPRINT).


Dr. Chertow arrived at Stanford in 2007 as Chief of the Nephrology Division.  He has received numerous awards for excellence in patient care, teaching, mentoring and research.  His clinical research interests are in clinical epidemiology, health services research, decision sciences and clinical trials.

Dr. Kurella Tamura is a clinical and health services investigator whose primary interest is in improving the quality of end-stage renal disease (ESRD) care among older adults. Her current work aims to describe outcomes (especially geriatric outcomes) in older patients and to compare the effectiveness of different ESRD management strategies.

Dr. Lafayette completed his fellowship at Stanford University and has been on faculty for many years. He is the director of the Stanford Glomerular Disease Center.  His current research is focused on developing a glomerulonephritis cohort study, including immunologic characterization. He has also completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. More  Dr. Lafayette's group continues to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. He is also actively studying renal disease in systemic amyloidosis.


Dr. Lenihan trained in Ireland before completing fellowships in nephrology and transplant nephrology at Stanford. He joined the Stanford faculty in 2015. His research focuses on issues related to kidney transplantation and living kidney donation.

Throughout her career, Dr. Leonard has devoted the majority of her effort to patient oriented research and mentoring junior investigators. Her overarching goal is to lead a vibrant, multidisciplinary, innovative research program that attracts new trainees to clinical research, serves as a launching pad for junior investigators, and improves bone health, nutrition, and clinical outcomes in children and adults with chronic disease. More  Her multidisciplinary research program is primarily focused on the impact of chronic diseases on bone metabolism and nutrition, with an emphasis on changes in body composition and skeletal density and structure during growth and aging, and in the context of inflammatory diseases, chronic kidney disease, glucocorticoid therapy, and bone marrow transplantation. She has identified unique windows of vulnerability for impaired bone accrual during early puberty, with a consequent detrimental impact on peak bone mass and likely implications for life long skeletal health and fracture risk.


Jonathan Maltzman, MD-PhD, FAST
Associate Professor of Medicine
Director of Basic Research, Nephrology

My laboratory has a longstanding interest in understanding fundamental aspects of immunological memory and regulation and their relationship to solid organ transplantation and cancer. I have been an independent investigator for a period of 9 years since completing my clinical training in Nephrology and post-doctoral training in Immunology and as an Instructor of Medicine at the University of Pennsylvania. More  

Dr. Meyer received his MD at Harvard University and completed his residency and fellowship there before joining the Stanford facullty in 1984. He is primarly based at the VA medical center in Palo Alto. His research focuses on identification of uremic solutes in patients with end-stage renal disease, and ways to improve treatment for these patients.

Dr. O'Shaughnessy was awarded a First Class Honors Degree in Medicine from the National University of Ireland, Galway, in 2005 and subsequently underwent clinical training in Internal Medicine and Nephrology in Ireland, Australia, and the United States. Michelle commenced a Nephrology Research Fellowship More  at Stanford University in 2013, where she completed a Master of Science Degree in Epidemiology and Clinical Research, supported by a Ben J. Lipps Research Fellowship from the American Society of Nephrology. Her research focuses on exploring differences in clinical outcomes (e.g. mortality, morbidity, kidney allograft survival) across glomerular disease subtypes, with the goal of identifying and ultimately targeting disease-specific risks. She will join the Nephrology Faculty as a Clinical Assistant Professor of Medicine in September 2016, when she plans to contribute to the activities of Stanford’s Glomerular Disease Center by leading investigator-initiated and industry-sponsored clinical trials and by establishing a Glomerular Disease Patient Registry. In her spare time, she enjoys travelling, attending music concerts, and yoga.


Dr. Rhee holds a dual doctoral degree from Harvard University and completed her postdoctoral fellowship at Stanford. She is a diabetes epidemiologist and health services investigator whose research focuses on comparative effectiveness of diabetes treatments in patients with chronic kidney disease, dietary modification for diabetes, and racial and ethnic differences in cardiometabolic disease risk factors and outcomes. 

Tammy Sirich, MD
Assistant Professor of Medicine (Nephrology)

Tammy L. Sirich is an instructor of medicine in the Division of Nephrology. She graduated from UC Berkeley with a bachelor's of science in chemistry. During her undergraduate time, she worked in an analytical chemistry research lab that specialized in mass spectrometry. She completed medical school at UC San Diego and internal medicine  More training at Santa Clara Valley Medical Center. Dr. Sirich completed nephrology fellowship training at Stanford University. During her training, she conducted research under the mentorship of Dr. Timothy Meyer, studying uremic solutes using mass spectrometry. She received a Career Development Award from the Veterans Affairs Research program. She continues to study the role of uremic solutes in kidney failure using novel techniques of mass spectrometry.


Dr. Tan is an Associate Professor of Medicine. She holds degrees with honors in Biomedical Engineering from Johns Hopkins University, received her MD and PhD from University of Rochester School of Medicine and Dentistry, and completed her Internal Medicine and Nephrology training at the Beth Israel Deaconess Medical Center in Boston MA. More  Dr. Tan joined the Division of Nephrology at Stanford University in 2000 and has had more than 15 years of experience as a Transplant Nephrologist. She served as Interim Medical Director of Adult Kidney and Pancreas Transplantation in 2015 and now serves as Clinical Director of the Kidney and Pancreas Transplant Program. Her academic interests focus on aging and senescence in kidney transplantation. She has conducted NIH-funded studies in organs from older deceased and living donors. She received a Masters degree in Epidemiology at Stanford University in 2014 and serves on national committees on transplant nephrology and living donor education policy.


Our research aims to improve the global quality of care for patients with Urologic conditions, with a particular focus on kidney cancer. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects.